L.A.M.Pharma - 500 Beiträge pro Seite
eröffnet am 15.02.02 15:27:15 von
neuester Beitrag 07.03.02 18:30:21 von
neuester Beitrag 07.03.02 18:30:21 von
Beiträge: 27
ID: 551.582
ID: 551.582
Aufrufe heute: 0
Gesamt: 1.333
Gesamt: 1.333
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 58 Minuten | 2445 | |
heute 09:04 | 1365 | |
vor 1 Stunde | 1255 | |
heute 08:27 | 962 | |
vor 1 Stunde | 852 | |
vor 52 Minuten | 806 | |
vor 1 Stunde | 664 | |
heute 08:57 | 564 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 17.754,14 | -0,12 | 168 | |||
2. | 2. | 145,64 | -0,07 | 122 | |||
3. | 3. | 2.379,26 | +0,78 | 77 | |||
4. | 5. | 6,7380 | +2,18 | 69 | |||
5. | 4. | 7,1800 | -2,97 | 68 | |||
6. | 6. | 3,7100 | +2,91 | 37 | |||
7. | 7. | 0,3991 | -0,72 | 37 | |||
8. | 12. | 0,0329 | +105,63 | 32 |
Bomben News un der Kurs geht gerade ab!!!!!!!!!!!!
Kaaaaaaaaaaaauuuuuuuuuuuufffffffffffeeeeeeennnnnnn
Salut
Kaaaaaaaaaaaauuuuuuuuuuuufffffffffffeeeeeeennnnnnn
Salut
Die News findet ihr bei yahoo.com
Finacial
Kürzel lamp
Salut
Finacial
Kürzel lamp
Salut
Da geht aber garnix ab!
Ist 0,98 gar nixxxxxxxxxxxxxxx!
Salut
Salut
nein
Der den Franken nicht Ehrt,
ist den Millionen nicht wert.
Salut
ist den Millionen nicht wert.
Salut
wir handeln hier mit euros, nicht mit franken!
Kauf dir Davnet!!!!!!!!!!!!!!!!!
Salut
Salut
hab ich schon.
Mein Beileid...............
0,002 EURO = PLEITE
Kauf dir lieber LAM Pharma und Du wirds mir Dankbar sein.
Salut
0,002 EURO = PLEITE
Kauf dir lieber LAM Pharma und Du wirds mir Dankbar sein.
Salut
kauft dir ANZA
+23% und super news
+23% und super news
so richtig mit den NULLEN zählen hast du es wohl nicht?
FSE
0,024 €
bei 0,020 € gekauft! sind aber nur 20% ????????????????
FSE
0,024 €
bei 0,020 € gekauft! sind aber nur 20% ????????????????
Ist ja auch ein Riesenumsatz...............0 Stücke!!!
Wo hast du denn gekauft?
Salut
Wo hast du denn gekauft?
Salut
ausserdem hat der kurs von LAM noch 20% rückschlagspotential. nach dem push der letzten tage kein wunder. bei ca. 0,80€ geh ich vieleicht rein.
wenn du dir den chart ansiehst, weist du wann.
Ich denke für 0,8 euro gibs die nicht mehr,eher wenn Du umrechnets müssten die eigentlich bei 1 euro stehen!
Salut
Salut
ich glaube dir ja, das es sicher noch eine ralley mit LAM gibt, aber nicht heute und nicht morgen. die bei 0,50 € rein sind nehmen ihre gewinne mit. deshalb nochmal 0,80 €.
als vergleich will ich dir BKN anbieten. da war ich bei. meine reißleine ist dann bei 3,90 € gerissen. waren eben nur 30% gewinn. hätte mehr sein können.
schönes wochenende, schont eure nerven.
hallo @ LUX 2001
so langsam komme ich dem einstiegskurs von 0,80 € nahe.
was ich dir gesagt habe, ist eingetroffen. 20% rückschlag
so langsam komme ich dem einstiegskurs von 0,80 € nahe.
was ich dir gesagt habe, ist eingetroffen. 20% rückschlag
keine angst bwrds, es geht noch weiter runter! bin bei
0,95$ short gegangen u. werde dabei bleiben bis 0.6$!
0,95$ short gegangen u. werde dabei bleiben bis 0.6$!
dan werden wir bei ,60 kaufen od.drücks du sie noch weiter runter ??
da hat ja einer zu früh gekauft! wir wollen welche zu ,50/60
jumanjii...ob dein short gehen nicht in die hose geht wenn du nich bald coverst!
0,6 sehe ich nicht!
morchel
0,6 sehe ich nicht!
morchel
New Research Report Issued on LAM Pharmaceutical Corp.
LEWISTON, N.Y., March 7 /PRNewswire-FirstCall/ -- LAM Pharmaceutical Corp. (OTC Bulletin Board: LAMP; FRANKFURT STOCK EXCHANGE: LAM), http://www.lampharm.com, announced today that a Research Report on the Company has been issued by General Research GmbH of Munich, Germany.
The thirty page Research Report was prepared in German and is posted on the Company`s website. The Report recommends a Long Term Buy Rating for the Company`s common stock and projects, milestone driven, improvements in stock prices and overall capitalization.
General Research GmbH is one of Germany`s most highly respected Research Publication firms. Their chief analyst, Dr. Georg Hochwimmer, has a PhD. in Biochemistry and advanced credentials in business. General Research GmbH`s many subscribers closely follow the recommendations of Dr. Hochwimmer.
http://biz.yahoo.com/prnews/020307/nyth001_1.html
morchel
LEWISTON, N.Y., March 7 /PRNewswire-FirstCall/ -- LAM Pharmaceutical Corp. (OTC Bulletin Board: LAMP; FRANKFURT STOCK EXCHANGE: LAM), http://www.lampharm.com, announced today that a Research Report on the Company has been issued by General Research GmbH of Munich, Germany.
The thirty page Research Report was prepared in German and is posted on the Company`s website. The Report recommends a Long Term Buy Rating for the Company`s common stock and projects, milestone driven, improvements in stock prices and overall capitalization.
General Research GmbH is one of Germany`s most highly respected Research Publication firms. Their chief analyst, Dr. Georg Hochwimmer, has a PhD. in Biochemistry and advanced credentials in business. General Research GmbH`s many subscribers closely follow the recommendations of Dr. Hochwimmer.
http://biz.yahoo.com/prnews/020307/nyth001_1.html
morchel
LAMP
Und noch etwas sehr Interessantes...
TheSUBWAY.com Announces Investment Opinion: Financial Targets
NOTE TO EDITORS: The Following Is An Investment Opinion Issued By TheSUBWAY.com
WESTON, FL, Mar 07, 2002 (INTERNET WIRE via COMTEX) -- Keep an eye on LAM Pharmaceutical Corp. (OTCBB: LAMP). The company just released big news. LAMP is down from almost $6.50 and could be a huge gainer in the short term. Other stock market standouts include Dell Computer Corporation (Nasdaq: DELL), up 1% on 20 million shares after being chosen for $25 million Technology Initiative for Oklahoma City Schools, Leap Wireless International (Nasdaq: LWIN), up 35% on 6 million shares and Allegiance Telecom Inc. (Nasdaq: ALGX), up 13% on 4 million shares after completing electronic link with Verizon Wholesale Systems.
"Shares of McData tumbled as much as 25 percent after the Company warned late Tuesday that it would not meet Wall Street`s financial targets for the first quarter, citing cautious spending on technology products by larger customers. On the flip-side, Sprint`s announcement that it was on track to meet 2002 financial targets gave Sprint shares almost a 10 percent hike, while other stocks in the space enjoyed similar gains." Stated Peter Antipatis in TheSUBWAY.com`s daily commentary. Continued at www.TheSUBWAY.com.
All material herein was prepared by Capital Research Group, Inc. (CRG) based upon information believed to be reliable. The information contained herein is not guaranteed by CRG to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on www.thesubway.com or mentioned herein. CRG has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. (one hundred twenty five thousand lamp) CRG intends to sell its shares. CRG has sold approximately fifty five thousand lamp shares to date. CRG may sell its shares for less than the target price given in this opinion. CRG`s affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Peter Antipatis, CRD number 2955420. CRG will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
GN
Und noch etwas sehr Interessantes...
TheSUBWAY.com Announces Investment Opinion: Financial Targets
NOTE TO EDITORS: The Following Is An Investment Opinion Issued By TheSUBWAY.com
WESTON, FL, Mar 07, 2002 (INTERNET WIRE via COMTEX) -- Keep an eye on LAM Pharmaceutical Corp. (OTCBB: LAMP). The company just released big news. LAMP is down from almost $6.50 and could be a huge gainer in the short term. Other stock market standouts include Dell Computer Corporation (Nasdaq: DELL), up 1% on 20 million shares after being chosen for $25 million Technology Initiative for Oklahoma City Schools, Leap Wireless International (Nasdaq: LWIN), up 35% on 6 million shares and Allegiance Telecom Inc. (Nasdaq: ALGX), up 13% on 4 million shares after completing electronic link with Verizon Wholesale Systems.
"Shares of McData tumbled as much as 25 percent after the Company warned late Tuesday that it would not meet Wall Street`s financial targets for the first quarter, citing cautious spending on technology products by larger customers. On the flip-side, Sprint`s announcement that it was on track to meet 2002 financial targets gave Sprint shares almost a 10 percent hike, while other stocks in the space enjoyed similar gains." Stated Peter Antipatis in TheSUBWAY.com`s daily commentary. Continued at www.TheSUBWAY.com.
All material herein was prepared by Capital Research Group, Inc. (CRG) based upon information believed to be reliable. The information contained herein is not guaranteed by CRG to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on www.thesubway.com or mentioned herein. CRG has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. (one hundred twenty five thousand lamp) CRG intends to sell its shares. CRG has sold approximately fifty five thousand lamp shares to date. CRG may sell its shares for less than the target price given in this opinion. CRG`s affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Peter Antipatis, CRD number 2955420. CRG will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
GN
ich glaube das ist heuer schon das 5. mal das the subway auf LAMP hinweist!
....looks great!
morchel
....looks great!
morchel
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
168 | ||
122 | ||
77 | ||
69 | ||
68 | ||
37 | ||
37 | ||
32 | ||
30 | ||
29 |
Wertpapier | Beiträge | |
---|---|---|
29 | ||
28 | ||
27 | ||
25 | ||
24 | ||
23 | ||
22 | ||
19 | ||
19 | ||
18 |